Hyperthyroidism: Methimazole Plus L-carnitine and Selenium

Last updated: August 31, 2021
Sponsor: Lo.Li.Pharma s.r.l
Overall Status: Active - Recruiting

Phase

N/A

Condition

Female Hormonal Deficiencies/abnormalities

Thyroid Disease

Thyroid Disorders

Treatment

N/A

Clinical Study ID

NCT04946123
L-carnitine Hyperthyroidism
  • Ages > 18
  • All Genders

Study Summary

The study aims to investigate the benefits of methimazole treatment in patients with hyperthyroidism, associated with supplementation of L-carnitine and Selenium.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosis of hyperthyroidism requiring therapy with methimazole

Exclusion

Exclusion Criteria:

  • Drug and alcohol abuse;
  • Pregnancy;
  • Medically uncontrolled psychiatric conditions;
  • Interfering therapies (lithium, interferone, TKI, amiodarone)

Study Design

Total Participants: 60
Study Start date:
July 05, 2021
Estimated Completion Date:
July 31, 2022

Connect with a study center

  • Azienda Ospedaliero-Universitaria Città della scienza e degli studi di Torino

    Torino, 10126
    Italy

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.